PMWC 2018 Silicon Valley Conference
A deep dive into every aspect of precision medicine

Conference Co-Hosts

University Of Michigan

Leading institutions will share their experiences on how to implement new clinical practices – to make precision medicine the standard for all constituents.

At PMWC 2018 Silicon Valley you'll learn about:

  • AI/machine learning
  • Big data solutions
  • Cancer care advancements
  • Clinical enablement
  • CRISPR-Cas9 genome editing tool
  • Emerging technology & innovations
  • Genomic data analysis
  • Government initiatives (including the All of Us Research Program)
  • Immunotherapy
  • Liquid biopsy applications
  • Microbiome
  • Mobile health
  • Next-generation sequencing

January 22-24 may just end up being your most productive three days of 2018!

More than 350 speakers, 5 tracks, 65 sessions, & 1,500 attendees

PMWC 2018 Silicon Valley is for professionals exploring the forefront of Precision Medicine:

Genomic Data Analysis / Next-Gen Sequencing

We have 16 sessions planned that address the aspects of genomic data analysis, including:

  • Clinical applications including ctDNA analysis
  • Extracting knowledge to drive discovery
  • Developing rare disease diagnostics and therapeutics
  • Employing automated literature analysis
  • AI/machine learning
  • Delivering reports that translate into clinical actions
Presenters include:
Eric Schadt (Sema4), Christa Lese Martin (Geisinger), Aris Baras (Regeneron Genetics Center), Kenneth Pienta (Johns Hopkins Univeristy School of Medicine), and Lincoln Nadauld (Intermountain Healthcare)

Two Showcases, featuring more than 35 companies:
Genomic Profiling – commercial advancements and innovations of new methods and instruments for DNA/RNA sequencing
Clinical Dx – commercial advancements in expedited, cost-effective, and accurate clinical diagnosis

Immunotherapy / Cancer Care

We have 15 sessions planned that discuss cell-based immunotherapies, including:

  • New immunotherapy strategies
  • Targeting the tumor microenvironment
  • Challenges in patient companion diagnostics
  • Marrying a drug with a diagnostic
  • Bringing the next generation
  • Bringing IO biomarkers to the clinic
  • Cancer vaccines to boost the immune system
  • Total cost of IO care
  • Immunotherapy IP protection
  • New strategies for molecular diagnostic oncology testing
  • How the molecular tumor board is operating
  • New strategies for improving patient survivorship
  • Role of radiation therapy in cancer care
  • AI's impact on cancer care

Presenters include:
Ira Mellman (Genentech), Stephen Kingsmore (Rady Children’s Institute for Genomic Medicine), Jeffrey Bluestone (Parker Institute), Lawrence Fong (UCSF), Jennifer Wargo (MD Anderson), Alexander Baras (John Hopkins Hospital), Marty Tenebaum (Cancer Commons), Lincoln Nadauld (Intermountain Healthcare), and Quynh-Thu Le (Stanford Health Care)

IO Showcase, featuring more than 35 companies: the latest technologies in cell-based immunotherapies, cancer vaccines, patient selection processes, and more

Artificial Intelligence / Machine Learning

We have 9 sessions planned that address how AI will cure cancer, including:

  • Requirements for a scalable AI/machine learning systems framework
  • AI expedition of patient diagnosis
  • Impact of AI in pre-clinical and clinical drug discovery and development process
  • Challenges and rewards of bringing AI to the clinic for health and disease management

Presenters include:
Atul Butte (UCSF), Chris Cournoyer (N-of-One), Diane Wuest (GNS Healthcare), Alex Zhavoronkov (Insilico Medicine), Jessica Mega (Verily), Jurgi Camplong (Sophia Genetics), Adams Dudley (UCSF), Peter Donnelly (Welcome Trust), Mark Kiel (Genomenon), Thomas Wilckens (InnVentis), and Eric Lefkofsky (Tempus)

AI and Data Science Showcase, featuring more than 50 companies: the latest innovations in pre-clinical and clinical drug discovery, patient diagnosis and treatment, and scalable systems frameworks

Additional PMWC highlights
Luminary and Pioneer Award Ceremony on Sunday, January 21, honoring:
  • Dr. Elizabeth Blackburn (Salk Institute)
  • Dr. Emmanuelle Charpentier (Max Planck Institute)
  • Sir John Bell (Oxford University
  • Dr. Ron Levy (Stanford University)
  • Dr. Alan Ashworth (UCSF)
Exhibition with over 35 emerging and established companies and organizations showcasing their products and services.
Find the complete list of exhibiting companies on our website.

These are exiting times in Genomic Health and Precision Medicine – revolutionizing our approach to research, health, and healthcare.

We are honored to be witnesses to these breathtaking developments.

Don’t miss out. Join this timely conference now!
REGISTER

Late breaking: Dawn Barry leaves Illumina to lead Luna DNA -Blockchain Disrupting Healthcare Industry

“Every individual holds a valuable piece of the puzzle to understand disease and health, and researchers are all in need of more data. Discovery is hindered by putting the majority of data into small silos. Breaking down data silos and bringing individuals together will more quickly aggregate enough samples to rise above the complexity of genomics and identify disease candidates.” – Dawn Barry, President and Co-Founder, Luna DNA

Read More

Interview Dawn Barry the new President and Co-founder of Luna DNA

Q: In a sentence, what is Luna DNA going to do?

Read More

JPM18: Edico Genome, Illumina, Invitae, Regeneron, Thermo Fisher Scientific,… and the list goes on

It’s been an announcement-packed JPMorgan Healthcare Conference in San Francisco this week!

Read More

At PMWC 2018 Silicon Valley CMS Administrator Seema Verma Discusses the Future of Health Care

Genomics-based testing or new immunotherapies that revolutionize cancer care are changing how we approach disease…

Read More

Interview with Dr. Frank Lee, Global Healthcare & Life Sciences Industry Leader at IBM; Chief Architect, IBM Reference Architecture for Genomics – Speaker at PMWC 2018 Silicon Valley

Q: As a pioneer in high performance architectures for genomic research what are the biggest challenges that you see clients dealing with as they invest in precision medicine initiatives?

Read More

Q&A with Ira Mellman, PhD, Vice President, Cancer Immunology, Genentech – Speaker at PMWC 2018 Silicon Valley

Q: Immunotherapy is considered a huge game-changer and holds a lot of promises. Is the hype around immunotherapy justified? What are some of the exciting developments in the recent years?

Read More

Interview with Atul Sharan, Co-founder and CEO, CellMax Life

Q: CellMax has developed non-invasive blood tests based on Circulating tumor cells CTC. How do you see these tests being adopted clinically?

Read More

Q&A with Matthew Kane, Co-founder & CEO, Precision BioSciences – Speaker at PMWC 2018 Silicon Valley

Q: What are the benefits of the Precision BioSciences’ ARCUS genome editing platform and what makes it unique?

Read More

Q&A with Jon Heimer, CEO, Olink Proteomics – Speaker at PMWC 2018 Silicon Valley

Q: Olink has been rapidly growing its’ library of human protein biomarker assays. What are the popular clinical applications for your biomarker panels?

Read More

2017 Review: A Clear Paradigm Shift from a one-size-fits-all model to personalized healthcare

2017 saw technology innovations, new therapies and diagnostics, value-based healthcare, and clinical protocol advancements as huge drivers, moving the needle…

Read More

Q&A with Peter Donnelly, Director, Wellcome Trust Centre for Human Genetics (Oxford) – Speaker at PMWC 2018 Silicon Valley

Q: How will genomics transform healthcare and how will it impact medicine? Beyond genetics and genomics what other data is relevant and why?

Read More

PMWC Interview with Janusz Dutkowski, Ph.D., Co-founder & CEO, Data4Cure – Speaker at PMWC 2018 Silicon Valley

Q: What are some of the key unique ideas behind the Biomedical Intelligence Cloud? What contextual knowledge do you bring in?

Read More

Q&A with Bob Terbrueggen, President & CEO, DxTerity – Speaker at PMWC 2018 Silicon Valley

Q: What are the challenges that the field of genomic research will face in the next five years?

Read More

Q&A with Mark Kiel, CSO and Co-founder, Genomenon – Speaker at PMWC 2018 Silicon Valley

Q: What are the challenges facing clinical interpretation of NGS data today?

Read More

Precision Medicine Jan 22-24th – learn from the experts at PMWC Silicon Valley 2018

Genomic Data Analysis / Next-Gen Sequencing, Immunotherapy / Cancer Care, & Artificial Intelligence / Machine Learning are all extensively covered at the conference, January 22-24

Read More
University of Michigan

About us:
The Precision Medicine World Conference (PMWC), in its 13th installment, will take place in Silicon Valley on January 22-24, 2018. The program will traverse innovative technologies, thriving initiatives, and clinical case studies that enable the translation of precision medicine into direct improvements in health care. Conference attendees will have an opportunity to learn first-hand about the latest developments and advancements in precision medicine and cutting-edge new strategies and solutions that are changing how patients are treated.

Agenda highlights:

    • More than 70 sessions with 350+ thought-provoking, insightful talks that cover all facets of precision medicine
    • Four tracks will showcase sessions on the latest advancements in precision medicine which include, but are not limited to:
    • Immuno-oncology
    • Cancer and rare disease diagnostics
    • Biomarker and companion diagnostics
    • Big data approaches
    • NGS applications
    • AI and machine learning applications
    • Advancements in liquid biopsy applications
    • Wellness & Aging
    • CRISPR
    • The human microbiome
    • Infectious disease ID and monitoring
    • The importance of patient engagement
    • 3-D technologies
    • Updates on data and regulatory policies
    • Metabolomics in precision medicine
    • mHealth and Telehealth

About us:
The Precision Medicine World Conference (PMWC), in its 13th installment, will take place in Silicon Valley on January 22-24, 2018. The program will traverse innovative technologies, thriving initiatives, and clinical case studies that enable the translation of precision medicine into direct improvements in health care. Conference attendees will have an opportunity to learn first-hand about the latest developments and advancements in precision medicine and cutting-edge new strategies and solutions that are changing how patients are treated.

Agenda highlights:

    • More than 70 sessions with 350+ thought-provoking, insightful talks that cover all facets of precision medicine
    • Four tracks will showcase sessions on the latest advancements in precision medicine which include, but are not limited to:
        • Immuno-oncology
        • Cancer and rare disease diagnostics
        • Biomarker and companion diagnostics
        • Big data approaches
        • NGS applications
        • AI and machine learning applications
        • Advancements in liquid biopsy applications
        • Wellness & Aging
        • CRISPR
        • The human microbiome
        • Infectious disease identification and monitoring
        • The importance of patient engagement
        • 3-D technologies
        • Updates on data and regulatory policies
        • Metabolomics in precision medicine
        • mHealth and Telehealth

One track will be dedicated to the various aspects of the All of Us Research Program, while another session will focus on educating California’s legislators.

 

Confirmed thought leaders include:

Sir John Bell

Sir John Bell

Regius Professor of Medicine, Oxford University

sally-davies

Dame Sally Davies

Chief Medical Officer, Department of Health, UK Government

BLA00002-Elizabeth-Blackburn

Elizabeth Blackburn

Nobel Laureate, President, Salk Institute for Biological Studies

George-Sledge

George Sledge

Professor, Division Chief, Stanford University Medical Center

Jeffrey Bluestone

Jeffrey Bluestone

CEO and President, Parker Institute for Cancer Immunotherapy

Christopher Ianelli

Christopher Ianelli

Founder and Chief Executive Officer,  iSpecimen

Kenneth J. Pienta

Kenneth J. Pienta

Director, Brady Urological Institute, Johns Hopkins Medicine

Roy Beveridge

Roy Beveridge

Senior Vice President & Chief Medical Officer, Humana

Kimberly Blackwell

Kimberly Blackwell

Professor of Medicine, Assistant Prof. of Radiation Oncology, Duke Cancer Institute

Joshua Denny

Joshua Denny

Professor of Biomedical Informatics & Medicine, Vanderbilt University Medical Center

Edward S. Kim

Edward S. Kim

Chair, Solid Tumor and Investigational Therapeutics, Levine Cancer Institute

Howard L. McLeod

Howard L. McLeod

Medical Director, Personalized Medicine Institute, Moffitt Cancer Center

Lee Newcomer

Lee Newcomer

SVP, UnitedHealthcare Oncology and Genetics

Vinod Khosla

Vinod Khosla

Partner and Founder of Khosla Ventures

Troy Brennan

Troy Brennan

Executive VP & CMO, CVS Health

Ira Mellman

Ira Mellman

VP, Cancer Immunology, Genentech

Event Highlights

When
January 22, 2018 8:00am to January 24, 2018 5:00pm
Where
Computer History Museum
1401 N Shoreline Blvd
Mountain View, CA 94043
Cost
$1850 by January 19th, 2018
Registration
3-Day Access to Talks, Exhibition & Reception:
See Registration Details

Registration: PMWC Conferences

Silicon Valley Jan 22-24, 2018

65+ Sessions 4 Tracks
350+ Speaker lineup
Access to the exhibition
Breakfast & lunch refreshments
Networking App
Award Reception

Having Trouble Registering? We accept all major credit cards. Select 'PayPal Check out' and press 'Pay with Debit or Credit Card'.
Click here or call (650)-961-8877 to contact the PMWC Team for Help.